跳至主要内容
临床试验/NCT00885300
NCT00885300已完成不适用

Cloxacillin as Prevention of Double Lumen Infection in Hemodialysis Patients

Shiraz University of Medical Sciences1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2008年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
catheter infection

研究概览

简要总结

The purpose of this study is to investigate whether cloxacillin lock is effective in prevention of double lumen infection.

详细描述

Double lumen infection is one of the causes of morbidity and mortality in hemodialysis patients. Many strategies used to prevent it and one of them is antibiotic lock. Thus we select chronic hemodialysis patients and divided them into 2 groups. One group received cloxacillin and heparin as catheter lock and the second group received only heparin lock.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • hemodialysis for 3 months
  • at least 2 time dialysis/week

排除标准

  • active infection
  • acute renal failure

研究组 & 干预措施

1

Experimental

cloxacillin 100 mg/ml + heparin 1000iu/ml as catheter lock at the end of hemodialysis

干预措施: cloxacillin (Drug)

1

Experimental

cloxacillin 100 mg/ml + heparin 1000iu/ml as catheter lock at the end of hemodialysis

干预措施: heparin (Drug)

2

Active Comparator

heparin 1000iu/ml as catheter lock at the end of hemodialysis

干预措施: heparin (Drug)

结局指标

主要结局

catheter infection

时间窗: 6 months

次要结局

未报告次要终点

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验